User profiles for Vincent-Philippe Lavallée
Vincent-Philippe LavalléeCHU Sainte-Justine Research Center and Université de Montréal Verified email at umontreal.ca Cited by 2611 |
Regenerative lineages and immune-mediated pruning in lung cancer metastasis
Developmental processes underlying normal tissue regeneration have been implicated in
cancer, but the degree of their enactment during tumor progression and under the selective …
cancer, but the degree of their enactment during tumor progression and under the selective …
[PDF][PDF] Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia
…, I Boivin, T MacRae, J Krosl, C Thiollier, VP Lavallée… - Cancer cell, 2019 - cell.com
To identify therapeutic targets in acute myeloid leukemia (AML), we chemically interrogated
200 sequenced primary specimens. Mubritinib, a known ERBB2 inhibitor, elicited strong anti-…
200 sequenced primary specimens. Mubritinib, a known ERBB2 inhibitor, elicited strong anti-…
GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo
C Pabst, A Bergeron, VP Lavallée, J Yeh… - Blood, The Journal …, 2016 - ashpublications.org
Acute myeloid leukemia (AML) is a genetically heterogeneous hematologic malignancy,
which is initiated and driven by a rare fraction of leukemia stem cells (LSCs). Despite the …
which is initiated and driven by a rare fraction of leukemia stem cells (LSCs). Despite the …
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
VP Lavallée, I Baccelli, J Krosl, B Wilhelm, F Barabé… - Nature …, 2015 - nature.com
Using next-generation sequencing of primary acute myeloid leukemia (AML) specimens, we
identified to our knowledge the first unifying genetic network common to the two subgroups …
identified to our knowledge the first unifying genetic network common to the two subgroups …
[PDF][PDF] Transcriptional basis of mouse and human dendritic cell heterogeneity
…, H Gudjonson, Y Pritykin, D Deep, VP Lavallée… - Cell, 2019 - cell.com
Dendritic cells (DCs) play a critical role in orchestrating adaptive immune responses due to
their unique ability to initiate T cell responses and direct their differentiation into effector …
their unique ability to initiate T cell responses and direct their differentiation into effector …
[HTML][HTML] Expression of immunoproteasome genes is regulated by cell-intrinsic and–extrinsic factors in human cancers
Based on transcriptomic analyses of thousands of samples from The Cancer Genome Atlas,
we report that expression of constitutive proteasome (CP) genes (PSMB5, PSMB6, PSMB7) …
we report that expression of constitutive proteasome (CP) genes (PSMB5, PSMB6, PSMB7) …
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
…, JF Spinella, CY Yao, VP Lavallée… - Blood, The Journal …, 2020 - ashpublications.org
RUNX1 is mutated in ∼10% of adult acute myeloid leukemia (AML). Although most RUNX1
mutations in this disease are believed to be acquired, they can also be germline. Indeed, …
mutations in this disease are believed to be acquired, they can also be germline. Indeed, …
Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
Acute myeloid leukemias (AML) are characterized by mutations of tumor suppressor and
oncogenes, involving distinct genes in adults and children. While certain mutations have been …
oncogenes, involving distinct genes in adults and children. While certain mutations have been …
Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors
VP Lavallée, J Krosl, S Lemieux… - Blood, The Journal …, 2016 - ashpublications.org
In this study, we analyzed RNA-sequencing data of 14 samples characterized by biallelic
CEBPA (CEBPA bi ) mutations included in the Leucegene collection of 415 primary acute …
CEBPA (CEBPA bi ) mutations included in the Leucegene collection of 415 primary acute …
Genetic characterization of ABT-199 sensitivity in human AML
…, J Krosl, ME Bordeleau, B Lehnertz, VP Lavallée… - Leukemia, 2020 - nature.com
Acute myeloid leukemias (AML) with mutations in the NPM1 gene (NPM1c+) represent a
large AML subgroup with varying response to conventional treatment, highlighting the need to …
large AML subgroup with varying response to conventional treatment, highlighting the need to …